Krónikus obstruktív tüdőbetegség (COPD): ki dolgozik rajta

Intézményenként egy kártya. Válassz célpontot, és csak az azon dolgozó csoportok maradnak.

• Minden célpont
• NRF2 0
• MAPK 0
• NLRP3 0
• PI3K 0
• STAT3 0
• GLP-1 1
• SIRT1 0
• PDE4 0
• AKT 0
• ERK 0
• STING 0
• TP53 0
• TSLP 2
• JAK 0
• TLR4 0
• IL-6 2
• MMP-9 0
• mTOR 0
• PPAR 0
• CFTR 0
• GPX4 0
• IL-17 0
• PD-L1 1
• TNF 0
• VEGF 0
• AMPK 0
• HIF-1 0
• PD-1 0
• SGLT2 0
• EGFR 0
• JNK 0
• COX-2 0
• CTNNB1 0
• CXCR4 0
• HDAC 0
• IL-1 0
• BDNF 0
• BRD4 0
• CD40 0
• DPP-4 0
• FTO 0
• HER2 0
• HMGB1 0
• KRAS 0
• MDM2 0
• METTL3 0
• PTEN 0
• RANKL 0
• TIGIT 0
• YAP 0
• ABL1 0
• AQP4 0
• BCMA 0
• CD38 0
• CDKN2A 0
• FAK 0
• FGFR 0
• G6PD 0
• HTT 0
• IL-13 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Pulmonary Hypertension in COPD : from Observation to Emerging Novel therapeutic Insights and eXploration (PHOENIX)

  Universitat Zurich· Zurich, Svájc· EU contribution 292 119 EUR· until 2028. dec.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  CellCourier: programmable drug delivery via combinatorial cell targeting and generative design of tailored binding peptides

  Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit und Umwelt Gmbh· Neuherberg, Németország· EU contribution 150 000 EUR· until 2027. jún.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-JU-RIA

  GUIDE-AI – Guiding your treatment with current evidence

  Charite - Universitaetsmedizin Berlin· Berlin, Németország· EU contribution 4 895 668 EUR· until 2029. dec.· 8 countries

• European Commission (Horizon Europe) · HORIZON-ERC-SYG

  Smart Detectors for Darkfield X-ray Imaging (SmartX)

  Technische Universitaet Muenchen· Muenchen, Németország· EU contribution 10 840 961 EUR· until 2031. márc.· 3 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Development of an Advanced Airway-On-A-Chip Model to Investigate Neuronal Hypersensitivity in Chronic Cough (REVEAL)

  Universitaetsklinikum Aachen· Aachen, Németország· EU contribution 1 498 775 EUR· until 2029. dec.

  The disease is named only in the funder's project summary, not in the title.

5 of 15 running projects, newest first. Listed amounts together: 50,5 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 27
• Organoids 7
• Mendelian Randomization Analysis 69
• CRISPR-Cas Systems 1
• Gene Expression Profiling 69
• Sequence Analysis, RNA 7
• Whole Genome Sequencing 4
• Proteomics 31
• Metabolomics 34
• Mass Spectrometry 6
• Flow Cytometry 5
• Immunohistochemistry 5
• Liquid Biopsy 2
• Circulating Tumor DNA 1
• Magnetic Resonance Imaging 32
• Machine Learning 103
• Deep Learning 33
• Cohort Studies 227
• Genome-Wide Association Study 72

• Evaluating Perfusion Quantification for Phase-Resolved Functional Lung MRI Using Gaussian Filtering.

  NMR Biomed, 2026. nov.

• Characterization of airway mucus using quantitative MRI: an in vitro proof-of-concept study.

  Eur Radiol Exp, 2026. okt.

• Diagnostic Methods for Muscle Wasting in COPD: Strengths, Limitations and the Role of Nutritional Assessment.

  Nutrients, 2026. okt.

• Effective Connectivity and Clinical Correlates in Chronic Obstructive Pulmonary Disease.

  Int J Chron Obstruct Pulmon Dis, 2026. okt.

• Inflammation-Mediated Causal Effects of MRI-Defined Body-Composition Obesity Axes on Chronic Obstructive Pulmonary Disease, Asthma, and Allergic Rhinitis: A Mendelian Randomization Study.

  Int J Chron Obstruct Pulmon Dis, 2026. okt.

• Left precuneus ALFF is associated with arterial oxygenation and cognitive impairment in patients with COPD: a resting-state fMRI study.

  Front Neurol, 2026. aug.

• Single-slice Functional Lung MRI During Metronome-Paced Tachypnea Detects Changes in Regional Ventilation Dynamics After a Single Dose of Dual Bronchodilator Treatment in COPD.

  COPD, 2026. aug.

• Brain iron deposition mediates cognitive impairment in COPD: A possible imaging marker linking systemic inflammation to neurodegeneration.

  Pulmonology, 2026. júl.

• Precision treatment of COPD based on novel imaging phenotypes: a treatable traits approach.

  Respir Res, 2026. júl.

• Association between CMR-derived pulmonary artery pulse wave velocity and pulmonary risk factors: the multi-ethnic study of atherosclerosis COPD study.

  Magn Reson Imaging, 2026. júl.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.